S100A8 and S100A9 are highly expressed in inflamed tissue fluid, playing a key role in conditions like psoriatic and rheumatoid arthritis. Obesity, linked to elevated psoriasin levels, increases the risk of developing psoriasis in individuals with a BMI over 30. Here, S100A7 is linked to obesity disorder.